Psychiatry & Neurology, Child & Adolescent Psychiatry · Jupiter, FL
NPI
1336241207
Since 2006
Specialty
Psychiatry & Neurology, Child & Adolescent Psychiatry
Code 2084P0804X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
641 University Blvd, Su. 206
Jupiter, FL, 33458
Phone (561) 630-8530
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$38K
840 prescriptions
Company payments, 2025
$1,118
From 10 companies
Medicare prescription drug claims, 2024
In 2024, the drug Marshall L Teitelbaum prescribed most often to Medicare patients was Dextroamphetamine-Amphet Er (Dextroamphetamine/Amphetamine), with 69 prescriptions and refills. In total Marshall L Teitelbaum wrote 840 Medicare prescriptions that cost $38K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-19.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 69 | 69 | Under 11 | $2,248 |
| Duloxetine Hcl Generic | 62 | 115 | Under 11 | $1,429 |
| Lamotrigine Generic | 55 | 129 | Under 11 | $718 |
| Alprazolam Generic | 48 | 48 | 14 | $447 |
| Clonazepam Generic | 39 | 51 | Under 11 | $441 |
| Bupropion Xl Bupropion Hcl | 35 | 99 | Under 11 | $909 |
| Sertraline Hcl Generic | 33 | 71 | Under 11 | $295 |
| Escitalopram Oxalate Generic | 29 | 71 | Under 11 | $433 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 29 | 29 | Under 11 | $494 |
| Divalproex Sodium Er Divalproex Sodium | 28 | 34 | Under 11 | $2,044 |
| Lurasidone Hcl Generic | 25 | 26 | Under 11 | $1,000 |
| Lithium Carbonate Er Lithium Carbonate | 25 | 41 | Under 11 | $271 |
| Lorazepam Generic | 25 | 26 | Under 11 | $195 |
| Trazodone Hcl Generic | 21 | 46 | Under 11 | $225 |
| Buspirone Hcl Generic | 21 | 50 | Under 11 | $478 |
Brand drugs: 23 claims; generic drugs: 817 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marshall L Teitelbaum $1,118 ($1,118 in general payments such as food, travel and fees) from 10 companies. The largest payer was Collegium Pharmaceutical, Inc. with $294.
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. COLL | 11 | $294 |
| Corium, LLC | 15 | $268 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 8 | $191 |
| Supernus Pharmaceuticals, Inc. SUPN | 5 | $110 |
| Tris Pharma Inc | 4 | $85.88 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $49.44 |
| Vanda Pharmaceuticals Inc. VNDA | 2 | $44.63 |
| Lundbeck LLC | 1 | $26.71 |
| Janssen Pharmaceuticals, Inc JNJ | 1 | $24.21 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $23.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.